Category:
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Chamlion Completes 236 Million Yuan in Series B Fundraising
Chamlion notes the fundraising will be mainly used for the further expansion of the company's domestic and overseas business, including the in-depth promotion and upgrade of their existing product line, to consolidate the company's leading position in the field of dental digitalization.
Meridian Medical Technologies, a Kindeva Drug Delivery Company, Investing $100+ Million in Bridgeton, Missouri, Expansion
Meridian Medical Technologies which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.
Recuro Health Closes $47 Million Series B Financing Led by ARCH Venture Partners, Advancing Innovative Virtual-First Care Service
Recuro Health will use the proceeds to advance and scale its Digital Medical Home, which includes diagnostic-enabled Virtual Primary Care and Virtual Behavioral Health Solutions that are tailored to fit the healthcare needs of any population.
SentiAR Announces Close of $8.5 million Series B Financing
The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors, including TechWald Holding, VCapital, QRM Capital, and Harmonix Fund. The funding will allow the company to launch additional partnerships and wider clinical deployments.
U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
The funds from the DOD contract will enable Theradaptive to continue its work to meet regulatory requirements and scale up Good Manufacturing Practices-compliant manufacturing of the OsteoAdapt product in preparation for clinical studies.
Macrolux Completes Nearly CNY100 million Series A Round: Funding Led by Legend Capital
Legend Capital has long been paying attention to the investment in the field of medical devices and diagnostics with a focus on three major themes: first, major diseases, especially the unmet clinical needs of chronic diseases; second, the first and uniqueness in technology, which enables a company to become or have the potential to become a leading player in subdivided industries; the third is the "device +" investment opportunities brought by the integration of medical devices and interdisciplinary technologies such as AI, IoT and Big Data.
Previa Medical Raises €2.1 Mil for AI Solution to Prevent Sepsis
Sepsis is one of the leading causes of hospital deaths worldwide, with a 30-day mortality rate of 20 to 30%. SEPSI-SCORE therefore provides a much-needed solution to a major global public health issue.
JelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program
JelikaLite notes the pilot study data suggests that JelikaLite’s Cognilum medical device reduces symptoms of autism in young children and improves the quality of life of their families.
Dymicron Launches Regulation A+ Equity Crowdfunding Investment Offering
Dymicron has partnered with DealMaker for its self-hosted $15.8 million raise. Regulation A+ raise. Regulation A+ is a relatively new exemption which allows private companies to sell their shares to unaccredited investors.
Medical Device News Magazine
